Cadrenal Therapeutics, Inc. Common Stock
$4.355
USD
Last updated on --.
24h volume58.45K
24h highest4.5900 USD
24h lowest4.2700 USD
24h Price movement-1.91%
CVKD recent prices
24 Hours
-1.91%-$0.085
30 days
-28.49%-$1.735
60 days
-10.21%-$0.495
90 days
-45.56%-$3.645
Key data
Previous close4.4400 USD
Market cap15.27M USD
Volume58.45K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.8600 USD
Net income (FY)-11.89M USD
Revenue (FY)--
Last report dateMay 7, 2026
About Cadrenal Therapeutics, Inc. Common Stock
HeadquartersPONTE VEDRA
Employees (FY)5.00
Net income per employee (FY)-2.38M USD
Listed onNasdaq
CVKD conversion tables
 |  |
|---|---|
| 0.5 CVKD | 2.177 USD |
| 1 CVKD | 4.355 USD |
| 5 CVKD | 21.77 USD |
| 10 CVKD | 43.55 USD |
| |
|---|---|
| 0.5 USD | 0.11481 CVKD |
| 1 USD | 0.22962 CVKD |
| 5 USD | 1.148 CVKD |
| 10 USD | 2.296 CVKD |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CVKD is trading at $4.355, -1.91% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CVKD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CVKD is currently trading at $4.355, -1.91% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CVKD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CVKD's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CVKD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CVKD's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Cadrenal Therapeutics, Inc. Common Stock's market cap is currently 15.27M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume58.45K
24h highest4.5900 USD
24h lowest4.2700 USD
24h Price movement-1.91%
Start trade with CVKD Perpetual
Sign up to trade